Molnunat
200mg
Intended to target viral replication in COVID-19, designed to alleviate clinical symptoms and support recovery in patients with mild-to-moderate infection.
200mg
Intended to target viral replication in COVID-19, designed to alleviate clinical symptoms and support recovery in patients with mild-to-moderate infection.